MiMedx (MDXG.OB) Optimistic Despite Q3 Let Down
MiMedx Group Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, today announced its third-quarter 2010 results. For the three months ended September 30, 2010, the company reported revenues of $108,000 as compared to $0 for the third quarter of 2009. The company posted a net loss of $2.9 million, or $0.05 per diluted common share, for the third quarter, as compared to a net loss of $4.5 million, or $0.11 per diluted common share, for the comparable quarter of 2009. Stockholder's equity as of September 30, 2010, was $5.7 million, compared to $6.1 million as of…